Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Genetic Lingo

Genetic Lingo

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

Pedigree Analysis

Pedigree Analysis

Sex-linked Disorders

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

When X Does Not Mark the Spot: Autosomal Dominant and Recessive Forms of Renal Hypophosphatemic Rickets and Osteomalacia.

Current osteoporosis reports·2026

Same author

Real-world Effectiveness of Burosumab Across Age Groups: X-linked Hypophosphatemia (XLH) Disease Monitoring Program.

The Journal of clinical endocrinology and metabolism·2026

Same author

Real-world Impact of Treatment on Growth in Children With X-Linked Hypophosphatemia.

The Journal of clinical endocrinology and metabolism·2026

Same author

Postprandial serum phosphorus and calcium concentrations in adults and children with X-linked hypophosphatemia during burosumab treatment.

JBMR plus·2026

Same author

Can transient neonatal osteosclerosis be differentiated from malignant infantile osteopetrosis?

Bone reports·2025

Same author

Delayed diagnosis of X-linked hypophosphatemia in the absence of family history: a global unmet need.

JBMR plus·2025

Search research articles

Related Experiment Video

Updated: Aug 8, 2025

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Published on: September 22, 2017

Autosomal dominant osteopetrosis.

Lynda E Polgreen¹, Erik A Imel², Michael J Econs³

¹The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.

|March 2, 2023

Summary

This summary is machine-generated.

Autosomal dominant osteopetrosis (ADO) is a common genetic disorder causing dense bones due to osteoclast dysfunction, often from CLCN7 gene mutations. Current ADO management focuses on symptom relief and monitoring complications, with research exploring new therapies.

Keywords:

Genes/dominant Osteopetrosis/epidemiology Osteopetrosis/genetics Osteopetrosis/history Osteopetrosis/pathology Osteopetrosis/therapy

More Related Videos

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis

Published on: December 18, 2019

Related Experiment Videos

Last Updated: Aug 8, 2025

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Published on: September 22, 2017

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis

Published on: December 18, 2019

Area of Science:

Genetics and Molecular Biology
Skeletal Biology
Rare Diseases

Background:

Autosomal dominant osteopetrosis (ADO) is the most prevalent form of osteopetrosis, a rare genetic bone disorder.
It is characterized by generalized osteosclerosis, often presenting with a distinctive "bone-in-bone" radiographic appearance.
The condition typically arises from impaired osteoclast function, frequently linked to mutations in the chloride channel 7 (CLCN7) gene.

Approach:

This review synthesizes current knowledge on ADO.
It examines the historical context, diverse clinical presentations, and underlying genetic factors.
The review also explores emerging therapeutic strategies and management approaches.

Key Points:

ADO manifests with significant bone density due to osteoclast dysfunction, commonly caused by CLCN7 gene mutations.
Complications include bone fragility, cranial nerve impingement, marrow space encroachment, and compromised bone vascularity.
Phenotypic variability is substantial, even within affected families.

Conclusions:

Currently, ADO lacks disease-specific treatments, necessitating supportive care focused on complication monitoring and symptom management.
Understanding the disease's history, phenotype spectrum, and genetic basis is crucial for developing targeted therapies.
Ongoing research aims to identify novel therapeutic avenues for ADO patients.